Digital Health
Medacist Introduces RxAuditor Reconcile for Medication Observability
The next-generation platform provides reconciliation of medication activity supporting faster, more informed decision-making for patient safety Medacist,…
The next-generation platform provides reconciliation of medication activity supporting faster, more informed decision-making for patient safety
Medacist, the industry leader in drug diversion technology solutions,introduced RxAuditor Reconcile, a new addition to the company’s extensive product portfolio, designed to provide users the capability to close the loop on the medication use process and quickly identify anomalous activity in real time.
Built on the firm’s 24 years of industry-specific data, RxAuditor Reconcile supports RxAuditor Investigate to help healthcare professionals streamline and accelerate drug diversion investigations with actionable information. Powered by Medacist’s Genesis platform, the drug analytics solution leverages artificial intelligence and machine learning to provide organizations with standardized, collaborative workflows for drug diversion activities.
Recommended AI: How is Artificial Intelligence (AI) Changing the Future of Architecture?
“Medacist’s RxAuditor Reconcile delivers a simpler, faster, and more cost-effective solution for accountability in healthcare facilities,” said David J. Brzozowski Jr., CTO, Medacist. “The addition of this new product to our portfolio provides our customers with a powerful drug diversion detection solution that enhances medication observability by monitoring the entire drug chain of custody.”
The ongoing opioid crisis continues to boost the need for advanced analytical solutions as organizations have increased their vigilance in tracking dispensing patterns. To meet this need, RxAuditor Reconcile was designed to accommodate search capabilities consistently across all transaction types, including all care areas, all individuals, and all medications; to help protect healthcare facilities from legal, regulatory, and reputational risk. Unlike other standard industry solutions, drug diversion teams can use RxAuditor Reconcile to create a case from the transaction list for reconciled and non-reconciled transactions.
Read More: Mobile Advertising Needs More Than Just 5G
“At a time where health professionals are continuing to be deluged with more and more challenges in their workplaces, we are pleased to introduce RxAuditor Reconcile to the industry,” said David J. Brzozowski Sr., President & CEO, Medacist. “Medacist’s suite of analytics services continues to serve as an ally for healthcare workers by eliminating hours of manual audits with advanced algorithms. RxAuditor Reconcile saves time where it counts.”
Recommended AI: Top 10 Martech Platforms Every Marketing Team Love Having in their Stack
[To share your insights with us, please write to sghosh@martechseries.com]
The post Medacist Introduces RxAuditor Reconcile for Medication Observability appeared first on AiThority.
Keep it Short
By KIM BELLARD OK, I admit it: I’m on Facebook. I still use Twitter – whoops, I mean X. I have an Instagram account but don’t think I’ve ever posted….
Asian Fund for Cancer Research announces Degron Therapeutics as the 2023 BRACE Award Venture Competition Winner
The Asian Fund for Cancer Research (AFCR) is pleased to announce that Degron Therapeutics was selected as the winner of the 2023 BRACE Award Venture Competition….
Seattle startup Olamedi building platform to automate health clinic communications
A new Seattle startup led by co-founders with experience in health tech is aiming to automate communication processes for healthcare clinics with its software…
